Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01380925 · ClinicalTrials.gov registry record
The Jewels in Our Genes Study - an African American Family Study of Breast Cancer
A clinical trial, sponsored by University at Buffalo.
- Completed
- Registry status
- 330
- Enrollment target
NCT01380925 is a clinical trial that has completed, run by University at Buffalo. The registered enrollment target is 330 participants.
The verdict
NCT01380925 has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- 330 participants
- Enrollment target
Study Summary
The research team is studying why some African American families have multiple cases of breast cancer. This study will help to better understand if there are undiscovered genes unique to African Americans that may predict early breast cancer risk. Breast cancer survivors AND their relatives who are also breast cancer survivors are being recruited to the study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01380925
The ClinicalTrials.gov registry entry for NCT01380925 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University at Buffalo, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01380925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01380925 about?
NCT01380925 is a clinical study titled "The Jewels in Our Genes Study - an African American Family Study of Breast Cancer". The research team is studying why some African American families have multiple cases of breast cancer. This study will help to better understand if there are undiscovered genes unique to African Americans that may predict early breast cancer risk. Breast cancer survivors AND their relatives who ar...
What is the current status of trial NCT01380925?
This trial is currently completed. The enrollment target is 330 participants. The study started on 2010-10. Estimated completion is 2012-08.
Who is sponsoring clinical trial NCT01380925?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.